Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Open Forum Infectious Diseases
|
April 10, 2024
Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial <i>Acinetobacter baumannii-calcoaceticus</i> Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial
Sarah M McLeod, Alita A Miller, Khurram Rana, et al.
Journal of Biomolecular Screening
|
September 28, 2012
A high-throughput-compatible fluorescence anisotropy-based assay for competitive inhibitors of Escherichia coli UDP-N-acetylglucosamine acyltransferase (LpxA)
Adam B Shapiro, Philip L Ross, Ning Gao, et al.
Antimicrobial Agents and Chemotherapy
|
October 29, 2014
Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor
Asha S Nayar, Thomas J Dougherty, Folkert Reck, et al.
Antimicrobial Agents and Chemotherapy
|
July 24, 2013
Improvement of the pharmacokinetics and in vivo antibacterial efficacy of a novel type IIa topoisomerase inhibitor by formulation in liposomes
Adam B Shapiro, Joseph Newman, Kosalaram Goteti, et al.
Journal of Biomolecular Screening
|
November 10, 2011
A homogeneous, high-throughput-compatible, fluorescence intensity-based assay for UDP-N-acetylenolpyruvylglucosamine reductase (MurB) with nanomolar product detection
Adam B Shapiro, Stephania Livchak, Ning Gao, et al.
Journal of Biomolecular Screening
|
May 14, 2014
Discovery of ATP-Competitive Inhibitors of tRNAIle Lysidine Synthetase (TilS) by High-Throughput Screening
Adam B Shapiro, Helen Plant, Jarrod Walsh, et al.
ACS Infectious Diseases
|
April 8, 2020
<i>In Vitro</i> Characterization of ETX1317, a Broad-Spectrum β-Lactamase Inhibitor That Restores and Enhances β-Lactam Activity against Multi-Drug-Resistant <i>Enterobacteriales</i>, Including Carbapenem-Resistant Strains
Alita A Miller, Adam B Shapiro, Sarah M McLeod, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 27, 2012
Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides
Suzanne S Stokes, Robert Albert, Ed T Buurman, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2017
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii
Sarah M McLeod, Adam B Shapiro, Samir H Moussa, et al.
Journal of Bacteriology
|
July 19, 2021
Bacterial Cytological Profiling Identifies Rhodanine-Containing PAINS Analogs as Specific Inhibitors of <i>Escherichia coli</i> Thymidylate Kinase <i>In Vivo</i>
Elizabeth T Montaño, Jason F Nideffer, Joseph Sugie, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Open Forum Infectious Diseases
|
April 10, 2024
Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial <i>Acinetobacter baumannii-calcoaceticus</i> Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial
Sarah M McLeod, Alita A Miller, Khurram Rana, et al.
Journal of Biomolecular Screening
|
September 28, 2012
A high-throughput-compatible fluorescence anisotropy-based assay for competitive inhibitors of Escherichia coli UDP-N-acetylglucosamine acyltransferase (LpxA)
Adam B Shapiro, Philip L Ross, Ning Gao, et al.
Antimicrobial Agents and Chemotherapy
|
October 29, 2014
Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor
Asha S Nayar, Thomas J Dougherty, Folkert Reck, et al.
Antimicrobial Agents and Chemotherapy
|
July 24, 2013
Improvement of the pharmacokinetics and in vivo antibacterial efficacy of a novel type IIa topoisomerase inhibitor by formulation in liposomes
Adam B Shapiro, Joseph Newman, Kosalaram Goteti, et al.
Journal of Biomolecular Screening
|
November 10, 2011
A homogeneous, high-throughput-compatible, fluorescence intensity-based assay for UDP-N-acetylenolpyruvylglucosamine reductase (MurB) with nanomolar product detection
Adam B Shapiro, Stephania Livchak, Ning Gao, et al.
Journal of Biomolecular Screening
|
May 14, 2014
Discovery of ATP-Competitive Inhibitors of tRNAIle Lysidine Synthetase (TilS) by High-Throughput Screening
Adam B Shapiro, Helen Plant, Jarrod Walsh, et al.
ACS Infectious Diseases
|
April 8, 2020
<i>In Vitro</i> Characterization of ETX1317, a Broad-Spectrum β-Lactamase Inhibitor That Restores and Enhances β-Lactam Activity against Multi-Drug-Resistant <i>Enterobacteriales</i>, Including Carbapenem-Resistant Strains
Alita A Miller, Adam B Shapiro, Sarah M McLeod, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 27, 2012
Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides
Suzanne S Stokes, Robert Albert, Ed T Buurman, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2017
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii
Sarah M McLeod, Adam B Shapiro, Samir H Moussa, et al.
Journal of Bacteriology
|
July 19, 2021
Bacterial Cytological Profiling Identifies Rhodanine-Containing PAINS Analogs as Specific Inhibitors of <i>Escherichia coli</i> Thymidylate Kinase <i>In Vivo</i>
Elizabeth T Montaño, Jason F Nideffer, Joseph Sugie, et al.
Page
of 6